Zdrowie i gospodarka · 20/02/2002

FDA Releases Draft Guidance for Industry on Exercise-Induced Bronchospasm Drug Development

The Food and Drug Administration (FDA) has made available a draft guidance document to help pharmaceutical companies develop clinical trials for medications that prevent exercise-induced bronchospasm (EIB), a condition characterized by airway constriction during physical activity.